Crossmark

The effect of Sarcomeal® oral supplementation plus vitamin D3 on muscle parameters and metabolic factors in diabetic sarcopenia patients: study protocol of a randomized controlled clinical trial

Crossref DOI link: https://doi.org/10.1186/s13063-024-08700-x

Published Online: 2024-12-23

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Abdi Dezfouli, Ramin

Zargar Balajam, Narges

Shirazi, Sara

Heshmat, Ramin

Shafiee, Gita
License Information

Text and Data Mining valid from 2024-12-23

Version of Record valid from 2024-12-23
More Information

Article History

Received: 9 March 2024

Accepted: 12 December 2024

First Online: 23 December 2024

Declarations

:

: Not applicable.

: None of the authors of this study have any financial ties with Karen Company and do not receive a salary from them. In this study, Karen Company will only provide the product and will not pay any funds to the researchers.

Document is current

Any future updates will be listed below